Personalis Stock Forecast, Price & News

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Personalis in the last year. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Personalis stock.
View analyst ratings for Personalis or view top-rated stocks.

Wall Street analysts have given Personalis a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Personalis wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Personalis is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Personalis.

Personalis will be holding an earnings conference call on Wednesday, August 4th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

Personalis, Inc. (NASDAQ:PSNL) posted its quarterly earnings results on Wednesday, May, 5th. The company reported ($0.29) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.37) by $0.08. The firm earned $20.88 million during the quarter, compared to analyst estimates of $20.40 million. Personalis had a negative trailing twelve-month return on equity of 21.21% and a negative net margin of 55.43%.
View Personalis' earnings history.

Personalis' stock was trading at $6.02 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PSNL stock has increased by 257.5% and is now trading at $21.52.
View which stocks have been most impacted by COVID-19.

Personalis issued an update on its second quarter 2021 earnings guidance on Wednesday, May, 26th. The company provided earnings per share guidance of - for the period. The company issued revenue guidance of $21.30 million-$21.30 million, compared to the consensus revenue estimate of $21.23 million.

8 equities research analysts have issued 12-month price objectives for Personalis' shares. Their forecasts range from $28.00 to $50.00. On average, they expect Personalis' stock price to reach $36.88 in the next year. This suggests a possible upside of 71.4% from the stock's current price.
View analysts' price targets for Personalis or view top-rated stocks among Wall Street analysts.

17 employees have rated Personalis CEO John West on Glassdoor.com. John West has an approval rating of 75% among Personalis' employees.

Some companies that are related to Personalis include Burning Rock Biotech (BNR), Veracyte (VCYT), Fulgent Genetics (FLGT), RadNet (RDNT), Castle Biosciences (CSTL), Genetron (GTH), Renalytix AI (RNLX), DermTech (DMTK), Celcuity (CELC), Centogene (CNTG), Exagen (XGN), Enzo Biochem (ENZ), Progenity (PROG), Viridian Therapeutics (VRDN) and Vyant Bio (VYNT).
View all of PSNL's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Personalis investors own include Enphase Energy (ENPH), Pfizer (PFE), Dynavax Technologies (DVAX), QUALCOMM (QCOM), Advanced Micro Devices (AMD), NIO (NIO), NVIDIA (NVDA), Viking Therapeutics (VKTX), AbbVie (ABBV) and (APHA).

(PSNL) raised $100 million in an initial public offering on Thursday, June 20th 2019. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, BofA Merrill Lynch and Cowen and Company acted as the underwriters for the IPO and Oppenheimer was co-manager.

Personalis trades on the NASDAQ under the ticker symbol "PSNL."

Shares of PSNL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PSNL stock can currently be purchased for approximately $21.52.

Personalis has a market capitalization of $944.90 million and generates $78.65 million in revenue each year. The company earns $-41,280,000.00 in net income (profit) each year or ($1.20) on an earnings per share basis.

Personalis employs 234 workers across the globe.

The official website for Personalis is www.personalis.com.

Personalis is headquartered at 1330 O`BRIEN DRIVE, MENLO PARK CA, 94025.

Personalis' mailing address is 1330 O`BRIEN DRIVE, MENLO PARK CA, 94025. The company can be reached via phone at 650-752-1300 or via email at [email protected]